Seòmar agus comataidhean

The Scottish Government takes matters of building safety seriously. While building owners have responsibility for their properties, the matter of Large Panel System buildings has been considered by the Ministerial Working Group on Building and Fire Safety and discussed within the Cross Sector Building Safety Forum. This Forum has been established to ensure that potential building safety issues are identified and shared amongst those who may have an interest, to allow them to take action where necessary.

Owners are advised to engage appropriate expert consultants to advise them using the authoritative guidance on Large Panel Systems from the Building Research Establishment and the Institution of Structural Engineers

Scotland does not have a legislative provision for safety certification of Large Panel System buildings. Local authorities in Scotland have statutory powers under the Building (Scotland) Act 2003 to address buildings that pose a risk to public safety due to structural instability or other hazards.

Owners of LPS buildings can use the long established guidance from the Building Research Establishment to assess and manage their property and can use information from The Institution of Structural Engineers (IStructE) website: An update about Large Panel System (LPS) - The Institution of Structural Engineers.

As Minister for Higher Education, Further Education & Minister for Veterans, I was gifted a framed piece of ceramic artwork in June 2023 and a lithograph in May 2025. The framed ceramic artwork was included in my proactive release entry for June 2023, and the lithograph will be included in the May 2025 release, which is due to be published in late September. These can be found on the Scottish Government website at the following link: https://www.gov.scot/collections/ministerial-engagements-travel-and-gifts/

Since my appointment to this post in June I have not had a meeting with the Interim Chief Executive of NHS Grampian. I last met with Integration Authority Chief Officers, including the Chief Officer of Health and Social Care Moray, on 7 August 2025.

The Royal College of Obstetrics and Gynaecology, the professional body for Obstetricians and Gynaecologists in the UK, has recommended that women who believe they may have been exposed to stilbestrol (DES) in utero and who are concerned about the risks of vaginal and cervical cancer should be offered careful monitoring by annual colposcopic examinations in specialist centres.

Cervical screening is offered to women who live in Scotland and are aged between 25 and 64 years and we encourage all women to take up routine cervical screening appointments when invited.

Evidence for an increased risk of other cancers is less conclusive but participation in the National Breast Screening Programme is recommended. Pregnant women who know that they were exposed in utero to DES should inform their obstetrician and be aware of the increased risks of ectopic pregnancy and preterm labour.

The Scottish Government continues to fund the charity Health in Mind to deliver peer support services to those affected by historic forced adoption, including mothers and adoptees.

The Scottish Government have regular meetings with animal welfare organisations to discuss a range of welfare issues, including electronic shock collars. Furthermore Scottish Government officials recently met with the Scottish Canine Trainers Alliance to discuss this topic and will continue to engage with all stakeholders in this area going forward.

The Welfare of Dogs (Scotland) Act 2025 received Royal Assent on 19 March 2025 and introduced provisions to help ensure more informed and responsible dog ownership. Scottish Government officials have been working with key stakeholders over a period of months to develop a code of practice that should be followed by any person who is considering acquiring a dog to keep as a pet. There is already a wealth of information available to the public from welfare organisations including the Dogs Trust and the Scottish SPCA covering the safe purchase and ownership of a dog and we urge people considering getting a dog to follow the advice provided.

The Scottish Government is committed to increasing the safety of the people in Scotland under threat of being victims of transplant-related offences, including when those offences take place in other countries. The Human Tissue (Supply of Information about Transplants) (Scotland) Regulations 2025, which came into force on 1 July 2025, place a duty on all clinicians in Scotland to report to the UK Human Tissue Authority (1) suspicions about transplant-related crimes, that arise in the course of the clinician’s profession; and (2) information about overseas transplants. The duty applies to doctors and nurses practising in transplant and non-transplant centres across Scotland to ensure that the duty applies to all clinicians who may come across these patients.

The Regulations, which are in line with the arrangements that are in place in the rest of the UK, give clarity to clinicians in Scotland around when, and to whom, they should report relevant suspected offences in the Human Tissue (Scotland) Act 2006 or the Human Trafficking and Exploitation (Scotland) Act 2015. Guidance has been issued to clinicians about the implementation of the Regulations. The Regulations have been brought to the attention of NHS Boards and others in Scotland. Any reports that the Human Tissue Authority receives will be considered and, where relevant, findings will be passed on to Police Scotland for further investigation.

The Scottish Medicines Consortium (SMC) has received an abbreviated submission from the marketing authorisation holder, Vertex Pharmaceuticals, for vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), for the treatment of cystic fibrosis in people aged six years and older who have at least one non-class I mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The appraisal of Alyftrek® via this abbreviated process is ongoing, and NHS National Procurement (NP) is continuing to work with Vertex Pharmaceuticals on the commercial arrangements.

The medicine product page on the SMC’s website will be updated with the advice in due course, once published.

Some of the information you have requested – i) the number of licences applications made, and ii) how many licences were granted from 2012 to April 2025 to control mountain hares, is already in the public domain and can be found on NatureScot’s website at:

https://www.nature.scot/doc/freedom-information-request-licences-mountain-hare

The figures from April 2025 to-date are as follows:

Licences granted – 8

Licences Refused – 1

Licences in Progress – 1